These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 211756)

  • 41. In vitro neutralization of equid herpesvirus 1 mediated by recombinant antibodies.
    Molinková D; Skládal P; Celer V
    J Immunol Methods; 2008 Apr; 333(1-2):186-91. PubMed ID: 18329664
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Equid herpesvirus 1 infection in mice.
    Inazu M; Tsuha O; Kirisawa R; Kawakami Y; Iwai H
    J Vet Med Sci; 1993 Feb; 55(1):119-21. PubMed ID: 8384894
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Third International Havemeyer Workshop on Equine Herpesvirus type 1.
    Kydd JH; Slater J; Osterrieder N; Lunn DP; Antczak DF; Azab W; Balasuriya U; Barnett C; Brosnahan M; Cook C; Damiani A; Elton D; Frampton A; Gilkerson J; Goehring L; Horohov D; Maxwell L; Minke J; Morley P; Nauwynck H; Newton R; Perkins G; Pusterla N; Soboll-Hussey G; Traub-Dargatz J; Townsend H; Van de Walle GR; Wagner B
    Equine Vet J; 2012 Sep; 44(5):513-7. PubMed ID: 22888774
    [No Abstract]   [Full Text] [Related]  

  • 44. Cell mediated immunity in equine herpesvirus type 1 infection I. In vitro lymphocyte blastogenesis and serum neutralization antibody in normal parturient and aborting mares.
    Dutta SK; Campbell DL
    Can J Comp Med; 1977 Oct; 41(4):404-8. PubMed ID: 200317
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Equine herpesvirus neurologic disease: reflections from across the pond.
    Kydd JH; Smith KC
    J Vet Intern Med; 2006; 20(3):467-8. PubMed ID: 16734076
    [No Abstract]   [Full Text] [Related]  

  • 46. Proceedings of the Equine Herpesvirus-1 Havermeyer Workshop. San Gimignano, Tuscany. June 2004.
    Vet Immunol Immunopathol; 2006 May; 111(1-2):1-125. PubMed ID: 16481044
    [No Abstract]   [Full Text] [Related]  

  • 47. Equine herpesviruses: on the differentiation of respiratory from foetal strains of type 1.
    Studdert MJ; Blackney MH
    Aust Vet J; 1979 Oct; 55(10):488-92. PubMed ID: 231960
    [No Abstract]   [Full Text] [Related]  

  • 48. Safety and efficacy of a thymidine kinase negative equine herpesvirus-1 vaccine in young horses.
    Cornick J; Martens J; Martens R; Crandell R; McConnell S; Kit S
    Can J Vet Res; 1990 Apr; 54(2):260-6. PubMed ID: 2162730
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pathogenicity of equine herpesvirus 1 subtype 2 for foals and adult pony mares.
    Coignoul FL; Bertram TA; Cheville NF
    Vet Microbiol; 1984 Oct; 9(6):533-42. PubMed ID: 6095515
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transforming growth factor-beta induced by live or ultraviolet-inactivated equid herpes virus type-1 mediates immunosuppression in the horse.
    Charan S; Palmer K; Chester P; Mire-Sluis AR; Meager A; Edington N
    Immunology; 1997 Apr; 90(4):586-91. PubMed ID: 9176113
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Equid herpesvirus-induced immunosuppression is associated with lymphoid cells and not soluble circulating factors.
    Hannant D; O'Neill T; Ostlund EN; Kydd JH; Hopkin PJ; Mumford JA
    Viral Immunol; 1999; 12(4):313-21. PubMed ID: 10630790
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Equine herpesviruses. 6. Sequential infection of horses with types 2, 3 and 1.
    Wilks CR; Studdert MJ
    Aust Vet J; 1976 May; 52(5):199-203. PubMed ID: 183644
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Equine herpesvirus-1: dealing practically but effectively with an ever present threat.
    Gonzalez-Medina S; Newton JR
    Equine Vet J; 2015 Mar; 47(2):142-4. PubMed ID: 25644768
    [No Abstract]   [Full Text] [Related]  

  • 54. Vaccination of foals and pregnant mares with Duvaxyn EHV1, 4 vaccine.
    Studdert MJ
    Vaccine; 2002 Jan; 20(7-8):992. PubMed ID: 11803056
    [No Abstract]   [Full Text] [Related]  

  • 55. Deadly viral outbreak ravages European horses.
    Lesté-Lasserre C
    Science; 2021 Mar; 371(6536):1297. PubMed ID: 33766865
    [No Abstract]   [Full Text] [Related]  

  • 56. Neurologic disease induced by equine herpesvirus 1.
    Pursell AR; Sangster LT; Byars TD; Divers TJ; Cole JR
    J Am Vet Med Assoc; 1979 Sep; 175(5):473-4. PubMed ID: 227824
    [No Abstract]   [Full Text] [Related]  

  • 57. Genetic restriction of cytolysis during equid herpesvirus 1 subtype 2 infection.
    Bridges CG; Edington N
    Clin Exp Immunol; 1987 Nov; 70(2):276-82. PubMed ID: 2827921
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serological evidence of equine herpesvirus type 1 (EHV-1) activity in polo horses in Nigeria.
    Adeyefa CA
    Zentralbl Veterinarmed B; 1992 Oct; 39(8):628-30. PubMed ID: 1334303
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Equine interferons following exposure to equid herpesvirus-1 or -4.
    Edington N; Bridges CG; Griffiths L
    J Interferon Res; 1989 Aug; 9(4):389-92. PubMed ID: 2474039
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Latency of equine herpesvirus 4.
    Browning GF; Studdert MJ
    Vet Rec; 1989 Feb; 124(8):203. PubMed ID: 2538953
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.